Gene · 406949
Papers3,765
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
721 to 740 of 3,765
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| miRNAs Copy Number Variations Repertoire as Hallmark Indicator of Cancer Species Predisposition. | Genes (Basel) | 2022 | 35741808 | PubTator, text mining | PubMed |
| Circulating miRNAs as Potential Biomarkers for Patient Stratification in Bipolar Disorder: A Combined Review and Data Mining Approach. | Genes (Basel) | 2022 | 35741801 | PubTator, text mining | PubMed |
| Exploring the Core Genes of Schizophrenia Based on Bioinformatics Analysis. | Genes (Basel) | 2022 | 35741729 | PubTator, text mining | PubMed |
| HypoxaMIRs: Key Regulators of Hallmarks of Colorectal Cancer. | Cells | 2022 | 35741024 | PubTator, text mining | PubMed |
| Extraction-Free Absolute Quantification of Circulating miRNAs by Chip-Based Digital PCR. | Biomedicines | 2022 | 35740375 | PubTator, text mining | PubMed |
| MicroRNAs: Novel players in the diagnosis and treatment of cancer cachexia (Review). | Exp Ther Med | 2022 | 35720622 | PubTator, text mining | PubMed |
| Sevoflurane Inhibits Metastasis in Hepatocellular Carcinoma by Inhibiting MiR-665-Induced Activation of the ERK/MMP Pathway. | Cell Transplant | 2022 | 35699095 | PubTator, text mining | PubMed |
| Altered microRNA expression in severe COVID-19: Potential prognostic and pathophysiological role. | Clin Transl Med | 2022 | 35696619 | PubTator, text mining | PubMed |
| Epigenetic alterations induced by genotoxic occupational and environmental human chemical carcinogens: An update of a systematic literature review. | Mutat Res Rev Mutat Res | 2022 | 35690411 | PubTator, text mining | PubMed |
| Diagnostic, Prognostic, and Mechanistic Biomarkers of Diabetes Mellitus-Associated Cognitive Decline. | Int J Mol Sci | 2022 | 35682821 | PubTator, text mining | PubMed |
| Expression Profiles of Circulating MicroRNAs in XELOX-Chemotherapy-Induced Peripheral Neuropathy in Patients with Advanced Gastric Cancer. | Int J Mol Sci | 2022 | 35682716 | PubTator, text mining | PubMed |
| Current and Future Biomarkers in Multiple Sclerosis. | Int J Mol Sci | 2022 | 35682558 | PubTator, text mining | PubMed |
| Sulforaphane Enhanced Proliferation of Porcine Satellite Cells via Epigenetic Augmentation of SMAD7. | Animals (Basel) | 2022 | 35681828 | PubTator, text mining | PubMed |
| Clinical Value and Molecular Function of Circulating MicroRNAs in Endometrial Cancer Regulation: A Systematic Review. | Cells | 2022 | 35681531 | PubTator, text mining | PubMed |
| Unraveling the Pathogenesis of Asthma and Chronic Obstructive Pulmonary Disease Overlap: Focusing on Epigenetic Mechanisms. | Cells | 2022 | 35681424 | PubTator, text mining | PubMed |
| MicroRNA 320a and Membrane Antigens as Tools to Evaluate the Pathophysiology of Platelets Stored in Blood Banks. | Curr Issues Mol Biol | 2022 | 35678655 | PubTator, text mining | PubMed |
| miR-15a and miR-15b modulate natural killer and CD8+T-cell activation and anti-tumor immune response by targeting PD-L1 in neuroblastoma. | Mol Ther Oncolytics | 2022 | 35663229 | PubTator, text mining | PubMed |
| Advances in pediatric non-alcoholic fatty liver disease: From genetics to lipidomics. | World J Clin Pediatr | 2022 | 35663007 | PubTator, text mining | PubMed |
| Adiponectin Ameliorates Hyperglycemia-Induced Retinal Endothelial Dysfunction, Highlighting Pathways, Regulators, and Networks. | J Inflamm Res | 2022 | 35662872 | PubTator, text mining | PubMed |
| Discovering miRNAs Associated With Multiple Sclerosis Based on Network Representation Learning and Deep Learning Methods. | Front Genet | 2022 | 35656318 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406949/papers?page=37